Valion Bio names Lisa Wolf president and COO, adds two directors
The Nasdaq-listed biotech also disclosed a $7.74 million financing with 3i, LP tied to overdue payments under its Series C preferred stock terms.
SEC filing (2)
Latest
2 stories
Tuesday, September 1
Friday, August 14
Allarity completes stenoparib manufacturing campaign, gets key US patent and CLIA certification
The company reported second quarter 2026 results alongside a completed Phase 3-ready manufacturing run, a new patent through 2042, and in-house diagnostic testing capability.
SEC filing